DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
de Boer RH, Arrieta Ó, Yang CH et al.
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.
J Clin Oncol 2011;
29: 1067-1074
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.